Drugs / Qishe Pill
Trials 3
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT02294448 | Nov 2014 → Dec 2015 | — | Shanghai University of Traditional Chinese Medicine | Unknown | No outcome recorded |
| Phase 21 trial | ||||||
| Phase 2 | NCT01274936 | Mar 2012 → Feb 2015 | radiculopathy | Shanghai University of Traditional Chinese Medicine | Unknown | No outcome recorded |
| Phase 41 trial | ||||||
| Phase 4 | NCT01875562 | May 2012 → Oct 2013 | radiculopathy | Shanghai University of Traditional Chinese Medicine | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Qishe Pill | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02294448 ↗ |
| Modality | Traditional medicine (herbal / TCM) | “Qishe Pill, a compound traditional Chinese herbal medicine” NCT01274936 ↗ |
| Route | Oral | “which should be taken orally with water (240mL) after a minimum 10-hour fast” NCT02294448 ↗ |